A Sickle CEll Disease ComplicatioN Trial

NCT02604368 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

210

Enrollment

INDUSTRY

Sponsor class

Conditions

Sickle Cell Disease

Interventions

DRUG: SC411
DRUG: Placebo

Sponsor

Micelle BioPharma Inc